Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Windecker

Showing results (711-720 of 1,417) with videos related to

Pageof 142
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 26, 2013
Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantationMaria D Radu, Lorenz Räber, Jungho Heo, et al.
The American Journal of Cardiology|December 8, 2016
Impact of Patient and Lesion Complexity on Long-Term Outcomes Following Coronary Revascularization With New-Generation Drug-Eluting StentsKonstantinos C Koskinas, Masanori Taniwaki, Fabio Rigamonti, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 2, 2010
Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound studyParham Eshtehardi, Stéphane Cook, Simon Wandel, et al.
European Heart Journal. Acute Cardiovascular Care|December 29, 2016
Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE scoreRoland Klingenberg, Soheila Aghlmandi, Lorenz Räber, et al.
European Heart Journal. Acute Cardiovascular Care|July 2, 2021
'Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI': a post hoc analysis of the randomized GLOBAL LEADERS trialAmr S Gamal, Hironori Hara, Mariusz Tomaniak, et al.
JACC. Cardiovascular Interventions|January 23, 2016
Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting StentsJames B Hermiller, Mitchell W Krucoff, Dean J Kereiakes, et al.
Journal of the American Heart Association|February 21, 2016
Post-Procedural Troponin Elevation and Clinical Outcomes Following Transcatheter Aortic Valve ImplantationKonstantinos C Koskinas, Stefan Stortecky, Anna Franzone, et al.
JACC. Cardiovascular Interventions|March 26, 2013
Clinical outcome of patients with and without diabetes mellitus after percutaneous coronary intervention with the resolute zotarolimus-eluting stent: 2-year results from the prospectively pooled analysis of the international global RESOLUTE programSigmund Silber, Patrick W Serruys, Martin B Leon, et al.
American Heart Journal|August 4, 2018
Impact of total ischemic time on manual thrombus aspiration benefit during primary percutaneous coronary interventionSarah Hugelshofer, Marco Roffi, Fabienne Witassek, et al.
Journal of the American Heart Association|December 29, 2023
Quantitative Flow Ratio to Predict Non-Target-Vessel Events Before Planned Staged Percutaneous Coronary Intervention in Patients With Acute Coronary SyndromeSarah Bär, Raminta Kavaliauskaite, Tatsuhiko Otsuka, et al.
Pageof 142

Showing results (711-720 of 1,417) with videos related to

Sort By:
Pageof 142
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 26, 2013
Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantationMaria D Radu, Lorenz Räber, Jungho Heo, et al.
The American Journal of Cardiology|December 8, 2016
Impact of Patient and Lesion Complexity on Long-Term Outcomes Following Coronary Revascularization With New-Generation Drug-Eluting StentsKonstantinos C Koskinas, Masanori Taniwaki, Fabio Rigamonti, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 2, 2010
Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound studyParham Eshtehardi, Stéphane Cook, Simon Wandel, et al.
European Heart Journal. Acute Cardiovascular Care|December 29, 2016
Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE scoreRoland Klingenberg, Soheila Aghlmandi, Lorenz Räber, et al.
European Heart Journal. Acute Cardiovascular Care|July 2, 2021
'Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI': a post hoc analysis of the randomized GLOBAL LEADERS trialAmr S Gamal, Hironori Hara, Mariusz Tomaniak, et al.
JACC. Cardiovascular Interventions|January 23, 2016
Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting StentsJames B Hermiller, Mitchell W Krucoff, Dean J Kereiakes, et al.
Journal of the American Heart Association|February 21, 2016
Post-Procedural Troponin Elevation and Clinical Outcomes Following Transcatheter Aortic Valve ImplantationKonstantinos C Koskinas, Stefan Stortecky, Anna Franzone, et al.
JACC. Cardiovascular Interventions|March 26, 2013
Clinical outcome of patients with and without diabetes mellitus after percutaneous coronary intervention with the resolute zotarolimus-eluting stent: 2-year results from the prospectively pooled analysis of the international global RESOLUTE programSigmund Silber, Patrick W Serruys, Martin B Leon, et al.
American Heart Journal|August 4, 2018
Impact of total ischemic time on manual thrombus aspiration benefit during primary percutaneous coronary interventionSarah Hugelshofer, Marco Roffi, Fabienne Witassek, et al.
Journal of the American Heart Association|December 29, 2023
Quantitative Flow Ratio to Predict Non-Target-Vessel Events Before Planned Staged Percutaneous Coronary Intervention in Patients With Acute Coronary SyndromeSarah Bär, Raminta Kavaliauskaite, Tatsuhiko Otsuka, et al.
Pageof 142